Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-08

Clinical Trial Update: Spinal Cord Stimulation for Refractory Pain in Erythromelalgia [NA]

View source ↗

Summary

A clinical trial is evaluating spinal cord stimulation for refractory pain in erythromelalgia. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spinal cord stimulator (spinal cord stimulator)

Snippet

Sponsor: St. Olavs Hospital | Conditions: Erythromelalgia | NA | Status: RECRUITING